Management, control, and decision making in unexpected recurrent venous thromboembolism in COVID-19: a case report
Description
CONCLUSION: In the case of unexpected recurrent venous thromboembolism in coronavirus disease 2019, especially when patients are taking rivaroxaban or other new oral anticoagulants, such drugs should be substituted by warfarin, with routine follow-up
